FLORIDA / NEW YORK

561.316.3330

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

Growing Trends and Solutions for Improving Liver Health Management

Jon Gingrich, CEO, Echosens North America

Author Jon Gingrich, CEO, Echosens North America writes, “Nonalcoholic fatty liver disease (NAFLD) is an asymptomatic and underdiagnosed disease that affects 37% of U.S. adults and 70% of individuals with Type 2 diabetes. Nonalcoholic steatohepatitis (NASH), the more severe form of NAFLD marked by inflammation and ballooning, can lead to hepatic fibrosis, cirrhosis, and hepatocellular cancer (HCC) if left untreated.” Read more.